These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 23777825)

  • 1. Design, synthesis and evaluation of novel 2-hydroxypyrrolobenzodiazepine-5,11-dione analogues as potent angiotensin converting enzyme (ACE) inhibitors.
    Addla D; Jallapally A; Kanwal A; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2013 Aug; 21(15):4485-93. PubMed ID: 23777825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Evaluation of Novel 2-Hydroxypyrrolobenzodiazepine-5,11-dione Analogues as Potent Angiotensin Converting Enzyme (ACE) Inhibitors.
    Sun Y; Bai Y; He X; Bai Y; Liu P; Zhao Z; Chen X; Zheng X
    Molecules; 2017 Nov; 22(11):. PubMed ID: 29099799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and evaluation of novel 2-butyl-4-chloroimidazole derived peptidomimetics as Angiotensin Converting Enzyme (ACE) inhibitors.
    Jallapally A; Addla D; Bagul P; Sridhar B; Banerjee SK; Kantevari S
    Bioorg Med Chem; 2015 Jul; 23(13):3526-33. PubMed ID: 25922179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel 2-butyl-4-chloro-1-methylimidazole embedded chalcones and pyrazoles as angiotensin converting enzyme (ACE) inhibitors.
    Kantevari S; Addla D; Bagul PK; Sridhar B; Banerjee SK
    Bioorg Med Chem; 2011 Aug; 19(16):4772-81. PubMed ID: 21782455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of 3-(3-((9H-carbazol-4-yl)oxy)-2-hydroxypropyl)-2-phenylquinazolin-4(3H)-one derivatives to induce ACE inhibitory activity.
    Venkatesh R; Kasaboina S; Gaikwad HK; Janardhan S; Bantu R; Nagarapu L; Sastry GN; Banerjee SK
    Eur J Med Chem; 2015; 96():22-9. PubMed ID: 25874328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potent ACE inhibitors from 5-hydroxy indanone derivatives.
    Vulupala HR; Sajja Y; Bagul PK; Bandla R; Nagarapu L; Benerjee SK
    Bioorg Chem; 2018 Apr; 77():660-665. PubMed ID: 29502027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis and enzyme inhibitory activities of new trifluoromethyl-containing inhibitors for angiotensin converting enzyme.
    Ojima I; Jameison FA; Pete B; Radunz H; Schittenhelm C; Lindner HJ; Emith AE
    Drug Des Discov; 1994 Feb; 11(2):91-113. PubMed ID: 8075303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimal recognition of neutral endopeptidase and angiotensin-converting enzyme active sites by mercaptoacyldipeptides as a means to design potent dual inhibitors.
    Coric P; Turcaud S; Meudal H; Roques BP; Fournie-Zaluski MC
    J Med Chem; 1996 Mar; 39(6):1210-9. PubMed ID: 8632427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perindopril and ramipril phosphonate analogues as a new class of angiotensin converting enzyme inhibitors.
    Gomez C; Berteina-Raboin S; De Nanteuil G; Guillaumet G
    Bioorg Med Chem; 2013 Nov; 21(22):7216-21. PubMed ID: 24095015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of novel triazoles and mannich bases functionalized 1,4-dihydropyridine as angiotensin converting enzyme (ACE) inhibitors.
    Kumbhare RM; Kosurkar UB; Bagul PK; Kanwal A; Appalanaidu K; Dadmal TL; Banerjee SK
    Bioorg Med Chem; 2014 Nov; 22(21):5824-30. PubMed ID: 25300819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of novel keto-ACE analogues as domain-selective angiotensin I-converting enzyme inhibitors.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4612-5. PubMed ID: 16784850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
    Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
    Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and green synthesis of 2-(diarylalkyl)aminobenzothiazole derivatives and their dual activities as angiotensin converting enzyme inhibitors and calcium channel blockers.
    Kalavagunta PK; Bagul PK; Jallapally A; Kantevari S; Banerjee SK; Ravirala N
    Eur J Med Chem; 2014 Aug; 83():344-54. PubMed ID: 24980116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (4-Substituted-phenyl)-(5H-10,11-dihydro-pyrrolo [2,1-c][1,4] benzodiazepin-10-yl)-methanone derivatives as vasopressin receptor modulators.
    Venkatesan AM; Grosu GT; Failli AA; Chan PS; Coupet J; Saunders T; Mazandarani H; Ru X
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5003-6. PubMed ID: 16153837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of 2-substituted-N-carboxymethyl-1,5-benzothiazepin-4-ones and -1,4-benzothiazin-3-ones and their evaluation as angiotensin converting enzyme inhibitors.
    Trapani G; Latrofa A; Franco M; Liso G
    Farmaco; 1995 Feb; 50(2):107-12. PubMed ID: 7766274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of highly potent benzodiazepine gamma-secretase inhibitors: preparation of (2S,3R)-3-(3,4-difluorophenyl)-2-(4-fluorophenyl)-4- hydroxy-N-((3S)-1-methyl-2-oxo-5- phenyl-2,3-dihydro-1H-benzo[e][1,4]-diazepin-3-yl)butyramide by use of an asymmetric Ireland-Claisen rearrangement.
    Churcher I; Williams S; Kerrad S; Harrison T; Castro JL; Shearman MS; Lewis HD; Clarke EE; Wrigley JD; Beher D; Tang YS; Liu W
    J Med Chem; 2003 Jun; 46(12):2275-8. PubMed ID: 12773031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and discovery of new (3S,5R)-5-[4-(2-chlorophenyl)-2,2-dimethyl-5-oxopiperazin-1-yl]piperidine-3-carboxamides as potent renin inhibitors.
    Mori Y; Ogawa Y; Mochizuki A; Nakamura Y; Sugita C; Miyazaki S; Tamaki K; Matsui Y; Takahashi M; Nagayama T; Nagai Y; Inoue S; Nishi T
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7677-82. PubMed ID: 23122821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACE inhibitors hypothesis generation for selective design, synthesis and biological evaluation of 3-mercapto-2-methyl-propanoyl-pyrrolidine-3-imine derivatives as antihypertensive agents.
    Ismail MA; Nabil Aboul-Enein M; Abouzid KA; Abou El Ella DA; Ismail NS
    Bioorg Med Chem; 2009 May; 17(10):3739-46. PubMed ID: 19403313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Meta-substituted benzofused macrocyclic lactams as zinc metalloprotease inhibitors.
    Ksander GM; de Jesus R; Yuan A; Ghai RD; McMartin C; Bohacek R
    J Med Chem; 1997 Feb; 40(4):506-14. PubMed ID: 9046341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel ketomethylene inhibitors of angiotensin I-converting enzyme (ACE): inhibition and molecular modelling.
    Redelinghuys P; Nchinda AT; Chibale K; Sturrock ED
    Biol Chem; 2006 Apr; 387(4):461-6. PubMed ID: 16606345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.